Mobious Genomics has announced a prototype version of a new
immunoassay that identified a low concentration bacterial sample
within 40 seconds, vastly improving on the six - forty eight hours
it currently takes to identify the same...
Illumina has made available the world's first multi-sample
whole-genome genotyping arrays that allow researchers to analyse
two samples simultaneously - useful when studying genetic variation
in disease in greater detail.
Mirus Bio has made available a new RNAi tool that analyses gene
function in vivo that allows scientists to study the biological and
physiological impact of a change in gene expression, which is
useful in the identification of new...
Evotec and CHDI have formed a strategic partnership, which aims to
research and develop treatments for Huntington Disease (HD), a
genetic disorder that causes programmed degeneration of brain cells
and loss of intellectual faculties.
deCODE and Illumina have entered an agreement to develop and
commercialise DNA-based diagnostics, in which deCODE will use
Illumina's SNP genotyping platform to expand its contract
Gentra Systems has introduced its new versaGene DNA Cell
Purification Kit, which responds to the growing need for
high-quality DNA for sensitive downstream applications. The kit
uses chemistry and column design to purify DNA with...
According to a recent report, pharmacogenetics is unlikely to
become a reality within the next 15-20 years having been 'hyped' by
the media, who are unaware of the many gaps in current
understanding of how genetics relates...